From www.aicd.com.au: A secondary stock exchange listing can provide companies with enhanced access to capital and greater investor visibility but also brings increased complexity and costs.

Companies like Mesoblast and Immuron have successfully utilized dual listings, particularly on the Nasdaq, to tap into specialized investor interests, while Xero transitioned to a single ASX listing to improve liquidity and trading volumes.

The decision to pursue a dual listing requires careful consideration of the long-term benefits and associated costs relative to the company’s strategic goals.